Prevention of diabetic blindness

British Journal of Ophthalmology

Volumn 90, Issue 1, 2006, Pages 2-3

  Stefánsson, Einar ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ARGON LASER; BIOMICROSCOPY; BLINDNESS; DIABETIC RETINOPATHY; EDITORIAL; ELECTRORETINOGRAPHY; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; FLUOROPHOTOMETRY; HUMAN; LASER COAGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA MACULA EDEMA; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

BLINDNESS; DIABETIC RETINOPATHY; EARLY DIAGNOSIS; HUMANS; PUBLIC HEALTH;

EID: 29744448752     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.082065     Document Type: Editorial

References (21)

1. Kahn HA, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol 1974;78:58-67.
2. Sorsby A. The incidence and causes of blindness in England and Wales 1963-68. Department of Health and Social Security. Reports on Public Health and Medical Subjects, No 128. With an appendix on services available for incipient blindness. Rep Public Health Med Subj (Lond) 1972;0:1-72.
3. Ghafour IM, Allan D, Foulds WS. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol 1983;67:209-13.
4. Porta M, Allione A. Current approaches and perspectives in the medical treatment of diabetic retinopathy. Pharmacol Ther 2004;103:167-77.
5. Trautner C, Icks A, Haastert B, et al. Incidence of blindness in relation to diabetes. A population-based study. Diabetes Care 1997;20:1147-53.
6. Broadbent DM, Scott JA, Vora JP, Hording SP. Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study. Eye 1999;13(Pt 2):160-5.
7. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-7.
8. TDRSR Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology 1981;88:583-600.
9. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796-806.
10. Munier A, Gunning T, Kenny D, et al. Causes of blindness in the adult population of the Republic of Ireland. Br J Ophthalmol 1998;82:630-3.
11. Younis N, Broadbent DM, James M, et al. Current status of screening for diabetic retinopathy in the UK. Diabet Med 2002;19(Suppl 4):44-9.
12. Stefansson E, Bek T, Porta M, et al. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 2000;78:374-85.
13. Zoega GM, Gunnarsdottir T, Björnsdóttir S, et al. Screening compliance and visual outcome in diabetes. Acta Ophthalmol Scand (in press).
14. Agardh E, Agardh CD, Hansson-Lundblad C. The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diabet Med 1993;10:555-9.
15. Kristinsson JK. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis. Acta Ophthalmol Scand(Suppl) 1997:1-76.
16. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology 1984;91:1-9.
17. Jerneld B, Algvere P. Visual acuity in a diabetic population. Acta Ophthalmol 1987;65:170-7.
18. Harding S, Greenwood R, Aldington S, et al. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 2003;20:965-71.
19. Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmology 1989;96:255-64.
20. James M, Turner DA, Broadbent DM, et al. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ 2000;320:1627-31.
21. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 2001;44:156-63.